Opioid Peptides Directly Slow Cell Growth in the Developing Uterus
Opioid peptides (dynorphin, met-enkephalin, beta-endorphin) directly inhibited uterine cell proliferation in a developmental stage-dependent manner, with the strongest effects in immature uteri.
Quick Facts
What This Study Found
Opioid peptides directly inhibited uterine cell proliferation in a developmental stage-dependent manner: strongest in immature tissue, diminishing with maturation, with different receptor subtypes active at different stages.
Key Numbers
How They Did This
In-vitro study using cultured rat uterine cells from prepubertal, pubertal, and adult stages. Dynorphin, met-enkephalin, and beta-endorphin effects on proliferation measured. Receptor specificity determined with selective antagonists.
Why This Research Matters
Opioid control of uterine development explains why opioid exposure during puberty could affect reproductive organ development, relevant for adolescent opioid use and maternal opioid exposure.
The Bigger Picture
Opioid peptides aren't just about pain — they regulate tissue development. The uterine growth timing system using opioids adds reproduction to the expanding list of opioid-regulated body systems.
What This Study Doesn't Tell Us
In-vitro rat uterine cells. Human uterine development may differ. The in-vivo significance of opioid growth regulation needs confirmation.
Questions This Raises
- ?Does adolescent opioid exposure disrupt uterine development?
- ?Is the opioid growth inhibition protective against uterine cancer?
- ?Could opioid receptor dysregulation contribute to endometriosis or uterine fibroids?
Trust & Context
- Key Stat:
- Developmental control Opioid growth inhibition was strongest in immature uterine tissue — suggesting opioids time reproductive organ development during puberty
- Evidence Grade:
- Preliminary in-vitro evidence with clear developmental stage-dependency and receptor specificity in relevant reproductive tissue.
- Study Age:
- Published in 2003. Opioid regulation of reproductive tissue development continues to be studied.
- Original Title:
- Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.
- Published In:
- Cell proliferation, 36(3), 151-63 (2003)
- Authors:
- Környei, J L, Vértes, Z(2), Kovács, K A, Göcze, P M, Vértes, M
- Database ID:
- RPEP-00840
Evidence Hierarchy
Frequently Asked Questions
Do opioids affect uterine development?
Yes — this study shows opioid peptides directly slow uterine cell growth, especially in young, developing tissue. This has implications for adolescent opioid exposure and maternal opioid use during pregnancy.
Is this why opioid users have reproductive problems?
It contributes. If opioids suppress both ovarian hormones (previous study) AND uterine development, chronic opioid use during critical developmental periods could impair reproductive organ maturation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00840APA
Környei, J L; Vértes, Z; Kovács, K A; Göcze, P M; Vértes, M. (2003). Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.. Cell proliferation, 36(3), 151-63.
MLA
Környei, J L, et al. "Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.." Cell proliferation, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Developmental changes in the inhibition of cultured rat uter..." RPEP-00840. Retrieved from https://rethinkpeptides.com/research/kornyei-2003-developmental-changes-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.